• Chemicals
• Discovery / R&D
• Generics
• Market Trends
• Pharma Industry Trends
• Pricing & Reimbursement
• Regulatory
• Sales & Marketing
• Therapeutic

M&A in pharma

Explores the merits of mega-deal in contrast to a more measured portfolio growth strategy

The Internet is transforming the way in which business is conducted; it also offers the potential for significant change in the pharmaceutical sector. At present the direct on-line sale of medicines to European consumers occurs only rarely though this may be about to change as entrepreneurs establish web-based pharmacies and challenge the status quo. Although regulatory barriers stand in the way of widespread growth in e-pharmacy, the attitudes of the EC legislators may be about to change.

E-Pharmacies in Europe: Will the Internet Revolutionise Drug Sales? is a timely publication that focuses on the role and attitudes of the key players which will be affected by e-pharmacy, and which will also drive its development.

The report sets out to evaluate the current situation and to look at how the picture may change in the future.

Topics covered include:

• Review of regulations surrounding on-line pharmaceutical sales



• Analysis of the parties opposing e-commerce and insight into their lobby groups



• Careful discussion of the role of chain pharmacies, drugstores and wholesalers



• Forecasts of the likely e-pharmacy market in Europe

Content

1: Current status of e-pharmacy in Europe

2: Regulatory barriers


3: Can Europe learn from the US model?

4: Key players in e-pharmacy in Europe

5: Future developments

6: The impact of e-pharmacy